236 related articles for article (PubMed ID: 10499914)
21. Thymic selection generates T cells expressing self-reactive TCRs in the absence of CD45.
Trop S; Charron J; Arguin C; Lesage S; Hugo P
J Immunol; 2000 Sep; 165(6):3073-9. PubMed ID: 10975818
[TBL] [Abstract][Full Text] [Related]
22. CD4+8- thymocytes bearing major histocompatibility complex class I-restricted T cell receptors: evidence for homeostatic control of early stages of CD4/CD8 lineage development.
Crompton T; Pircher H; MacDonald HR
J Exp Med; 1992 Sep; 176(3):903-7. PubMed ID: 1355104
[TBL] [Abstract][Full Text] [Related]
23. Thymic selection and thymic major histocompatibility complex class II expression are abnormal in mice undergoing graft-versus-host reactions.
Desbarats J; Lapp WS
J Exp Med; 1993 Sep; 178(3):805-14. PubMed ID: 8394404
[TBL] [Abstract][Full Text] [Related]
24. Enhanced T cell maturation and altered lineage commitment in T cell receptor/CD4-transgenic mice.
Lieberman SA; Spain LM; Wang L; Berg LJ
Cell Immunol; 1995 Apr; 162(1):56-67. PubMed ID: 7704911
[TBL] [Abstract][Full Text] [Related]
25. Disruption of intrathymic CD4-Ia interactions on immature CD4+CD8+ thymocytes results in diminished TCR expression on mature CD8+ T cell progeny.
Roberts JL; Sharrow SO; Singer A
Cell Immunol; 1995 Mar; 161(1):22-7. PubMed ID: 7867081
[TBL] [Abstract][Full Text] [Related]
26. The majority of postselection CD4+ single-positive thymocytes requires the thymus to produce long-lived, functional T cells.
Dyall R; Nikolić-Zugić J
J Exp Med; 1995 Jan; 181(1):235-45. PubMed ID: 7528769
[TBL] [Abstract][Full Text] [Related]
27. MHC class II-specific T cells can develop in the CD8 lineage when CD4 is absent.
Matechak EO; Killeen N; Hedrick SM; Fowlkes BJ
Immunity; 1996 Apr; 4(4):337-47. PubMed ID: 8612128
[TBL] [Abstract][Full Text] [Related]
28. Concomitant Disruption of
Chowdhary VR; Krogman A; Tilahun AY; Alexander MP; David CS; Rajagopalan G
J Immunol; 2017 Jun; 198(11):4413-4424. PubMed ID: 28468970
[TBL] [Abstract][Full Text] [Related]
29. Maturational arrest from CD4+8+ to CD4+8- thymocytes in a mutant strain (LEC) of rat.
Agui T; Oka M; Yamada T; Sakai T; Izumi K; Ishida Y; Himeno K; Matsumoto K
J Exp Med; 1990 Dec; 172(6):1615-24. PubMed ID: 2147947
[TBL] [Abstract][Full Text] [Related]
30. Analysis of cell surface antigens on glucocorticoid-treated rat thymocytes with monoclonal antibodies.
Tsuchida M; Konishi M; Jojima K; Naito K; Fujikura Y; Fukumoto T
Immunol Lett; 1994 Mar; 39(3):209-17. PubMed ID: 8034338
[TBL] [Abstract][Full Text] [Related]
31. A subset of CD4+ thymocytes selected by MHC class I molecules.
Bendelac A; Killeen N; Littman DR; Schwartz RH
Science; 1994 Mar; 263(5154):1774-8. PubMed ID: 7907820
[TBL] [Abstract][Full Text] [Related]
32. A cortisone sensitive CD3low subset of CD4+CD8- thymocytes represents an intermediate stage in intrathymic repertoire selection.
Crompton T; Ohashi P; Schneider SD; Pircher H; MacDonald HR
Int Immunol; 1992 Feb; 4(2):153-61. PubMed ID: 1535784
[TBL] [Abstract][Full Text] [Related]
33. Intrathymic T cell receptor (TcR) targeting in mice lacking CD4 or major histocompatibility complex (MHC) class II: rescue of CD4 T cell lineage without co-engagement of TcR/CD4 by MHC class II.
Müller KP; Kyewski BA
Eur J Immunol; 1995 Apr; 25(4):896-902. PubMed ID: 7737291
[TBL] [Abstract][Full Text] [Related]
34. Thymocyte development in major histocompatibility complex-deficient mice: evidence for stochastic commitment to the CD4 and CD8 lineages.
Crump AL; Grusby MJ; Glimcher LH; Cantor H
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10739-43. PubMed ID: 7902569
[TBL] [Abstract][Full Text] [Related]
35. Identification and cellular distribution of the rat interleukin-2 receptor beta chain: induction of the IL-2R alpha- beta+ phenotype by major histocompatibility complex class I recognition during T cell development in vivo and by T cell receptor stimulation of CD4+8+ immature thymocytes in vitro.
Park JH; Hanke T; Hünig T
Eur J Immunol; 1996 Oct; 26(10):2371-5. PubMed ID: 8898947
[TBL] [Abstract][Full Text] [Related]
36. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice.
Köntgen F; Süss G; Stewart C; Steinmetz M; Bluethmann H
Int Immunol; 1993 Aug; 5(8):957-64. PubMed ID: 8398989
[TBL] [Abstract][Full Text] [Related]
37. Reduced CD4 and CD8 expression in human thymuses treated with soluble CD4.
Zepp F; Ehlert K; Othmer M
Scand J Immunol; 1991 Aug; 34(2):185-95. PubMed ID: 1907765
[TBL] [Abstract][Full Text] [Related]
38. Antagonist peptide selects thymocytes expressing a class II major histocompatibility complex-restricted T cell receptor into the CD8 lineage.
Volkmann A; Barthlott T; Weiss S; Frank R; Stockinger B
J Exp Med; 1998 Sep; 188(6):1083-9. PubMed ID: 9743527
[TBL] [Abstract][Full Text] [Related]
39. The cytoplasmic domain of CD4 promotes the development of CD4 lineage T cells.
Itano A; Salmon P; Kioussis D; Tolaini M; Corbella P; Robey E
J Exp Med; 1996 Mar; 183(3):731-41. PubMed ID: 8642277
[TBL] [Abstract][Full Text] [Related]
40. Replacement of pre-T cell receptor signaling functions by the CD4 coreceptor.
Norment AM; Forbush KA; Nguyen N; Malissen M; Perlmutter RM
J Exp Med; 1997 Jan; 185(1):121-30. PubMed ID: 8996248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
